Found: 13
Select item for more details and to access through your institution.
Trabectedin.
- Published in:
- Oncologist, 2009, v. 14, n. 8, p. 794, doi. 10.1634/theoncologist.2009-0104
- By:
- Publication type:
- Article
FDA Approval Summary: Nivolumab Plus Ipilimumab for the Treatment of Patients with Hepatocellular Carcinoma Previously Treated with Sorafenib.
- Published in:
- Oncologist, 2021, v. 26, n. 9, p. 797, doi. 10.1002/onco.13819
- By:
- Publication type:
- Article
Evaluation of Serious Postmarket Safety Signals Within 2 Years of FDA Approval for New Cancer Drugs.
- Published in:
- Oncologist, 2020, v. 25, n. 4, p. 348, doi. 10.1634/theoncologist.2019-0653
- By:
- Publication type:
- Article
Clinical trial enrollment of adolescents and young adults with sarcoma.
- Published in:
- Cancer (0008543X), 2017, v. 123, n. 18, p. 3434, doi. 10.1002/cncr.30757
- By:
- Publication type:
- Article
Recommendations for Dose Selection for Adolescent Patients in Relevant Adult Oncology Clinical Trials.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 4, p. 956, doi. 10.1002/cpt.2467
- By:
- Publication type:
- Article
A phase 1 study of cabozantinib in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: Trial ADVL1211, a report from the Children's Oncology Group.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A phase I trial and pharmacokinetic study of a 24-hour infusion of trabectedin (Yondelis®, ET-743) in children and adolescents with relapsed or refractory solid tumors.
- Published in:
- 2012
- By:
- Publication type:
- journal article
A phase I trial and pharmacokinetic study of a 24-hour infusion of trabectedin (Yondelis®, ET-743) in children and adolescents with relapsed or refractory solid tumors.
- Published in:
- Pediatric Blood & Cancer, 2012, v. 59, n. 5, p. 865, doi. 10.1002/pbc.24201
- By:
- Publication type:
- Article
Intravenous pentamidine is effective as second line Pneumocystis pneumonia prophylaxis in pediatric oncology patients.
- Published in:
- Pediatric Blood & Cancer, 2008, v. 50, n. 4, p. 779, doi. 10.1002/pbc.21287
- By:
- Publication type:
- Article
Advancing Assessment, Analysis, and Reporting of Safety and Tolerability in Cancer Trials.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Patterns of thyroid hormone levels in pediatric medullary thyroid carcinoma patients on vandetanib therapy.
- Published in:
- International Journal of Pediatric Endocrinology, 2015, v. 2015, n. 1, p. 1, doi. 10.1186/1687-9856-2015-3
- By:
- Publication type:
- Article
Plasma and CNS pharmacokinetics of O4-benzylfolic acid (O4BF) and metabolite in a non-human primate model.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Plasma and CNS pharmacokinetics of O-benzylfolic acid (OBF) and metabolite in a non-human primate model.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 6, p. 1291, doi. 10.1007/s00280-010-1407-9
- By:
- Publication type:
- Article